Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Journal Mobile Options
Table of Contents
Vol. 6, No. 1, 2012
Issue release date: January – April
Section title: Published: March 2012

Open Access Gateway

Case Rep Gastroenterol 2012;6:162–165
(DOI:10.1159/000337499)

Splenic Injury and ERCP: A Possible Risk for Patients with Advanced Chronic Pancreatitis

Gaffney R.R.a · Jain V.b · Moyer M.T.b
aDepartment of Internal Medicine and bDivision of Gastroenterology/Hepatology, Penn State Hershey Medical Center, Hershey, Pa., USA
email Corresponding Author

Ryan R. Gaffney, DO

Department of Internal Medicine, Penn State Hershey Medical Center

P.O. Box 850, Mail Code H039, 500 University Drive, Hershey, PA 17033 (USA)

Tel. +1 570 436 5410, E-Mail rgaffney@hmc.psu.edu

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Abstract

Splenic injury is a rare but potentially life-threatening complication of endoscopy, with very few cases of endoscopic retrograde cholangiopancreatography (ERCP)-induced injury reported in the literature. Here we report a patient with chronic alcoholic pancreatitis who was diagnosed with a sub-capsular splenic laceration nearly 6 days after an ERCP. Clinicians should be alerted to the potential post-procedure complications associated with ERCP, particularly as this procedure is being utilized more frequently for the management of patients with complex hepatobiliary and pancreatic conditions.

© 2012 S. Karger AG, Basel


Article / Publication Details

First-Page Preview
Abstract of Published: March 2012

Published online: March 31, 2012
Issue release date: January – April

Number of Print Pages: 4
Number of Figures: 2
Number of Tables: 0

ISSN: (Print)
eISSN: 1662-0631 (Online)

For additional information: http://www.karger.com/CRG


Open Access License / Drug Dosage / Disclaimer

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.